Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021

Publisher Name :
Date: 01-May-2021
No. of pages: 350
Inquire Before Buying

The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest In Vitro Diagnostics agreements announced in the life sciences since 2014.

The report takes the reader through a comprehensive review In Vitro Diagnostics deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering In Vitro Diagnostics partnering deals.

The report presents financial deal term values for In Vitro Diagnostics deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the In Vitro Diagnostics partnering field; both the leading deal values and most active In Vitro Diagnostics dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 600 online deal records of actual In Vitro Diagnostics deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of In Vitro Diagnostics dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in In Vitro Diagnostics dealmaking since 2014, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading In Vitro Diagnostics deals since 2014. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in In Vitro Diagnostics dealmaking with a brief summary followed by a comprehensive listing of In Vitro Diagnostics deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2014, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of In Vitro Diagnostics partnering deals signed and announced since Jan 2014. The chapter is organized by specific In Vitro Diagnostics technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by In Vitro Diagnostics partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in In Vitro Diagnostics partnering and dealmaking since 2014.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of In Vitro Diagnostics technologies and products.

Key benefits

Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 provides the reader with the following key benefits:

In-depth understanding of In Vitro Diagnostics deal trends since 2014

Access to headline, upfront, milestone and royalty data

Detailed access to actual In Vitro Diagnostics contracts entered into by leading biopharma companies

Identify most active In Vitro Diagnostics dealmakers since 2014

Insight into terms included in a In Vitro Diagnostics partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 is intended to provide the reader with an in-depth understanding and access to In Vitro Diagnostics trends and structure of deals entered into by leading companies worldwide.

In Vitro Diagnostics Partnering Terms and Agreements includes:

Trends in In Vitro Diagnostics dealmaking in the biopharma industry since 2014

Analysis of In Vitro Diagnostics deal structure

Access to headline, upfront, milestone and royalty data

Access to In Vitro Diagnostics contract documents

Leading In Vitro Diagnostics deals by value since 2014

Most active In Vitro Diagnostics dealmakers since 2014

In Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides comprehensive access to available deals and contract documents for over 600 In Vitro Diagnostics deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How are sales and payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides the reader with the following key benefits:

In-depth understanding of In Vitro Diagnostics deal trends since 2014

Access to headline, upfront, milestone and royalty data

Detailed access to actual In Vitro Diagnostics contracts entered into by leading biopharma companies

Identify most active In Vitro Diagnostics dealmakers since 2014

Insight into terms included in a In Vitro Diagnostics partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in In Vitro Diagnostics dealmaking

2.1. Introduction
2.2. In Vitro Diagnostics partnering over the years
2.3. Most active In Vitro Diagnostics dealmakers
2.4. In Vitro Diagnostics partnering by deal type
2.5. In Vitro Diagnostics partnering by therapy area
2.6. Deal terms for In Vitro Diagnostics partnering
2.6.1 In Vitro Diagnostics partnering headline values
2.6.2 In Vitro Diagnostics deal upfront payments
2.6.3 In Vitro Diagnostics deal milestone payments
2.6.4 In Vitro Diagnostics royalty rates

Chapter 3 - Leading In Vitro Diagnostics deals

3.1. Introduction
3.2. Top In Vitro Diagnostics deals by value

Chapter 4 - Most active In Vitro Diagnostics dealmakers

4.1. Introduction
4.2. Most active In Vitro Diagnostics dealmakers
4.3. Most active In Vitro Diagnostics partnering company profiles

Chapter 5 - In Vitro Diagnostics contracts dealmaking directory

5.1. Introduction
5.2. In Vitro Diagnostics contracts dealmaking directory

Chapter 6 - In Vitro Diagnostics dealmaking by technology type

Chapter 7 - Partnering resource center

7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices

Appendix 1 - In Vitro Diagnostics deals by company A-Z
Appendix 2 - In Vitro Diagnostics deals by stage of development
Apppendix 3 - In Vitro Diagnostics deals by deal type
Appendix 4 - In Vitro Diagnostics deals by therapy area
Appendix 5 -Deal type definitions


About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: In Vitro Diagnostics partnering since 2014
Figure 2: Active In Vitro Diagnostics dealmaking activity since 2014
Figure 3: In Vitro Diagnostics partnering by deal type since 2014
Figure 4: In Vitro Diagnostics partnering by disease type since 2014
Figure 5: In Vitro Diagnostics deals with a headline value
Figure 6: In Vitro Diagnostics deals with an upfront value
Figure 7: In Vitro Diagnostics deals with a milestone value
Figure 8: In Vitro Diagnostics deals with a royalty rate value
Figure 9: Top In Vitro Diagnostics deals by value since 2014
Figure 10: Most active In Vitro Diagnostics dealmakers since 2014
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
  • 2020-2025 Global In-Vitro Diagnostics (IVD) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
    Published: 04-May-2021        Price: US 3360 Onwards        Pages: 112
    In vitro diagnostics are tests performed on samples such as blood or tissue taken from the human body. In vitro diagnostics can detect diseases or other diseases and can be used to monitor a person's overall health to help cure, treat or prevent disease. This report elaborates the market size, market characteristics, and market growth of the In-Vitro Diagnostics (IVD) industry, and breaks down according to the type, application, and consumption area of In-Vitro Diagnostics (IVD). The repo......
  • Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021
    Published: 01-May-2021        Price: US 3495 Onwards        Pages: 350
    The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest In Vitro Diagnostics agreements announced in the life sciences since 2014. The report takes the reader through a comprehen......
  • Global Rapid Medical Diagnostic Kits Sales Market Report 2021
    Published: 28-Apr-2021        Price: US 4000 Onwards        Pages: 152
    The global Rapid Medical Diagnostic Kits market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Medical Diagnostic Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Blood Glucose Testing......
  • 2021 Vietnam Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • 2021 Venezuela Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • 2021 Uruguay Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • 2021 United Arab Emirates Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • 2021 Ukraine Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • 2021 Turkey Transfusion Medicine Database: Supplier Shares, Volume and Sales Segment Forecasts for over 40 Tests
    Published: 26-Apr-2021        Price: US 1450 Onwards        Pages: 0
    This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and budget. LeadingMarketResearch.com provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for over 40 tests, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including: ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs